Home > Insider Trading > Filing (0001209191-21-025809)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1117480	Chimerix Inc	CMRX	Pharmaceutical Preparations (2834)	330903395

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1780556	David Jakeman	C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 100 Durham NC 27713	Principal Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-04-05	5,250	$2.35	103,989	No	4	M	Direct
Common Stock	Disposition	2021-04-05	1,284	$9.68	102,705	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-04-05	5,250	$0.00	5,250	$2.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-04-07	No	4	M	Direct

Footnotes

Includes 1,833 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on March 10, 2021.
The sales reported in this Form 4 were effected to cover the exercise price of a stock option expiring in April 2021 and were sold pursuant to a Rule10b5-1 trading plan adopted by the reporting person on February 26, 2021.
The range of sale prices received is $9.515 to $9.80. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares sold at each separate price.
Immediately exercisable.